NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation

Journal of Interventional Cardiac Electrophysiology

Volumn 33, Issue 1, 2012, Pages 93-100

  Fan, Jinqi ^a   Cao, Hua ^a   Su, Li ^a   Ling, Zhiyu ^a   Liu, Zengzhang ^a   Lan, Xianbin ^a   Xu, Yanping ^a   Chen, Weijie ^a   Yin, Yuehui ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Atrial natriuretic peptide; High sensitivity C reactive protein; N terminal pro brain natriuretic peptide; Paroxysmal atrial fibrillation; Pulmonary vein isolation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; C REACTIVE PROTEIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PULMONARY VEIN ISOLATION; AGED; BLOOD; CATHETER ABLATION; MIDDLE AGED; PULMONARY VEIN; RECURRENT DISEASE;

ADULT; AGED; ATRIAL FIBRILLATION; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY VEINS; RECURRENCE;

EID: 84861700112     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-011-9606-9     Document Type: Article

References (28)

1. Lo, L. W., & Chen, S. A. (2009). Developments and recent advances in catheter ablation of paroxysmal atrial fibrillation. Future Cardiology, 5, 557-565.
2. Goetze, J. P., Friis-Hansen, L., Rehfeld, J. F., Nilsson, B., & Svendsen, J. H. (2006). Atrial secretion of B-type natriuretic peptide. European Heart Journal, 27, 1648-1650. (Pubitemid 44025348)
3. Ellinor, P. T., Low, A. F., Patton, K. K., Shea, M. A., & Macrae, C. A. (2005). Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. Journal of the American College of Cardiology, 45, 82-86. (Pubitemid 40052031)
4. Shin, D. I., Jaekel, K., Schley, P., et al. (2005). Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Zeitschrift für Kardiologie, 94, 795-800. (Pubitemid 43029746)
5. Kallergis, E. M., Manios, E. G., Kanoupakis, E. M., et al. (2010). Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic peptide prohormone levels in patients with persistent atrial fibrillation. The American Journal of Cardiology, 105, 90-94.
6. Yamada, T., Murakami, Y., Okada, T., et al. (2006). Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation. The American Journal of Cardiology, 97, 1741-1744. (Pubitemid 43817862)
7. Malouf, J. F., Kanagala, R., Al, A. F., et al. (2005). High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. Journal of the American College of Cardiology, 46, 1284-1287. (Pubitemid 41615550)
8. Wazni, O., Martin, D. O., Marrouche, N. F., et al. (2005). C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart, 91, 1303-1305. (Pubitemid 41360947)
9. Casaclang-Verzosa, G., Gersh, B. J., & Tsang, T. S. (2008). Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology, 51, 1-11.
10. Wazni, O. M., Marrouche, N. F., Martin, D. O., et al. (2005). Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. Journal of the American Medical Association, 293, 2634-2640. (Pubitemid 40744248)
11. Burke, M. A., & Cotts, W. G. (2007). Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Failure Reviews, 12, 23-36. (Pubitemid 46629244)
12. Silver, M. A., Maisel, A., Yancy, C. W., et al. (2004). BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congestive Heart Failure, 10, 1-30.
13. Inoue, S., Murakami, Y., Sano, K., Katoh, H., & Shimada, T. (2000). Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. Journal of Cardiac Failure, 6, 92-96. (Pubitemid 30439442)
14. Wokhlu, A., Hodge, D. O., Monahan, K. H., et al. (2010). Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. Journal of Cardiovascular Electrophysiology, 21, 1071-1078.
15. Oral, H., Pappone, C., Chugh, A., et al. (2006). Circumferential pulmonary-vein ablation for chronic atrial fibrillation. The New England Journal of Medicine, 354, 934-941.
16. Shin, D. I., Deneke, T., Gorr, E., et al. (2009). Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic peptide plasma levels. Indian Pacing and Electrophysiology Journal, 9, 241-246.
17. Li, J., & Wang, L. (2006). B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart and Vessels, 21, 137-140.
18. Lee, S. H., Jung, J. H., Choi, S. H., et al. (2006). Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circulation Journal, 70, 100-104.
19. Chung, M. K., Martin, D. O., Sprecher, D., et al. (2001). C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 104, 2886-2891. (Pubitemid 33139098)
20. Psychari, S. N., Apostolou, T. S., Sinos, L., Hamodraka, E., Liakos, G., & Kremastinos, D. T. (2005). Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. The American Journal of Cardiology, 95, 764-767. (Pubitemid 40340139)
21. Lin, Y. J., Tsao, H. M., Chang, S. L., et al. (2010). Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. The American Journal of Cardiology, 105, 495-501.
22. Letsas, K. P., Weber, R., Burkle, G., et al. (2009). Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace, 11, 158-163.
23. Buob, A., Jung, J., Siaplaouras, S., Neuberger, H. R., & Mewis, C. (2006). Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Pacing and Clinical Electrophysiology, 29, 559-563. (Pubitemid 43886605)
24. Korantzopoulos, P., Kolettis, T. M., Kountouris, E., Siogas, K., & Goudevenos, J. A. (2005). Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? International Journal of Clinical Practice, 59, 881-885.
25. Cosgrave, J., Foley, J. B., Bahadur, K., Bennett, K., Crean, P., & Walsh, M. J. (2006). Inflammatory markers are not associated with outcomes following elective external cardioversion. International Journal of Cardiology, 110, 373-377. (Pubitemid 43841907)
26. Psychari, S. N., Chatzopoulos, D., Iliodromitis, E. K., Apostolou, T. S., & Kremastinos, D. T. (2011). C-reactive protein, interleukin 6, and N-terminal pro-brain natriuretic peptide following cardioversion of atrial fibrillation: is there a role of biomarkers in arrhythmia recurrence? Angiology, 62, 310-316.
27. Ellinor, P. T., Low, A., Patton, K. K., Shea, M. A., & MacRae, C. A. (2006). C-reactive protein in lone atrial fibrillation. The American Journal of Cardiology, 97, 1346-1350.
28. Rizos, I., Rigopoulos, A. G., Kalogeropoulos, A. S., et al. (2010). Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence. Journal of Human Hypertension, 24, 447-457.